Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: To all: I've noticed that some posters are asking
You must also remember that the acquisitioner must convince the acquisitionee, those words maybe made up, that the stock is as good or better than cash. That can be a much harder proposition than it sounds. Companies being acquired want to see S/P history along with strong guidance that suggest the stock will be moving up in value. For a company like Patriot that could be a hard sell with lack of substantial, positive, history to present. I think stopping at 20 million shares and sitting on the remaining reserves makes plenty of since.
Share
New Message
Please login to post a reply